News | September 25, 2025
Evonik launches MaxiPure Polysorbate 80 for injectable drug formulations
Ultra-high purity surfactant for biologics and parenteral drug formulations
Ultra-high purity surfactant for biologics and parenteral drug formulations
Hengrui is eligible to receive regulatory and commercial milestone payments of up to US$1.093 billion
Alkem's Pertuza is an affordable, indigenously-developed and manufactured biosimilar of pertuzumab
Prolia is a prescription medicine used to treat osteoporosis in women
The positive opinion is based on results from KOMET, the largest and only placebo-controlled, double-blind global Phase III trial in this patient population
The new Houston site, Lilly's eighth U.S. manufacturing facility announced since 2020, will focus on domestic production of small molecule synthetic medicines
All drug substance for Moderna’s authorized Spikevax (COVID-19 mRNA vaccine) targeting the SARS-CoV-2 LP.8.1 variant is produced at the company’s facility in Laval, Quebec
Importantly, the combination of giredestrant and everolimus was well tolerated
Tezspire nearly eliminated the need for surgery, reducing surgical intervention by 98 per cent
Conducted entirely in Europe across forty sites in five countries, this rigorous study met all clinical endpoints
Subscribe To Our Newsletter & Stay Updated
